Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Source: PubMed
JACC. Basic to translational science
Mar, 2023;8 (3): 359-370.
Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.
Gail A Van Norman
Author Information
Gail A Van Norman: Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, USA.
PMID: 37034284
DOI: 10.1016/j.jacbts.2022.12.012
Abstract
No abstract text available.
Keywords
drugs and device marketing
ethics
off-label marketing
off-label use
References
J Manag Care Pharm. 2012 Sep;18(7):506-15 [PMID:
22971204
]
J Am Board Fam Pract. 2005 Sep-Oct;18(5):414-8 [PMID:
16148253
]
JAMA Intern Med. 2022 Feb 01;182(2):206-217 [PMID:
34902005
]
Health Aff (Millwood). 2011 Dec;30(12):2318-27 [PMID:
22147859
]
Int J Risk Saf Med. 2012;24(4):221-31 [PMID:
23135337
]
PLoS Med. 2008 Oct 28;5(10):e210 [PMID:
18959472
]
J Am Acad Psychiatry Law. 2021 Mar;49(1):53-59 [PMID:
33234538
]
Int J Cardiol. 2022 Mar 1;350:96-103 [PMID:
34979147
]
Sci Rep. 2013 Nov 06;3:3146 [PMID:
24192909
]
Pharmacol Ther. 2020 Oct;214:107619 [PMID:
32599009
]
JAMA. 1997 Apr 16;277(15):1238-43 [PMID:
9103350
]
Food Drug Law J. 2006;61(3):577-83 [PMID:
16989041
]
JAMA. 2019 Aug 6;322(5):405-406 [PMID:
31386116
]
CJEM. 2001 Oct;3(4):321-2 [PMID:
17610779
]
J Law Med Ethics. 2013 Fall;41(3):654-64 [PMID:
24088156
]
JAMA. 2008 Apr 16;299(15):1759-61 [PMID:
18413865
]
JAMA. 2006 Jun 21;295(23):2759-64 [PMID:
16788131
]
CMAJ. 2006 May 9;174(10):1397 [PMID:
16682702
]
JAMA. 2008 Apr 16;299(15):1800-12 [PMID:
18413874
]
Facial Plast Surg Clin North Am. 2007 May;15(2):251-4, viii [PMID:
17544942
]
Elife. 2014 Aug 14;3:e02956 [PMID:
25124673
]
Neurology. 1989 Jul;39(7):969-71 [PMID:
2544829
]
PLoS Med. 2010 Aug 17;7(8):e1000318 [PMID:
20808955
]
Ann Intern Med. 2010 Aug 3;153(3):158-66 [PMID:
20679560
]
J Law Med Ethics. 2009 Fall;37(3):476-86, 396 [PMID:
19723258
]
JAMA Intern Med. 2016 Jan;176(1):55-63 [PMID:
26523731
]
Br J Psychiatry. 2003 Jul;183:22-7 [PMID:
12835239
]
J Vasc Interv Radiol. 2020 Apr;31(4):622-628 [PMID:
32094048
]
Sci Eng Ethics. 2012 Jun;18(2):247-61 [PMID:
21327723
]
Am J Psychiatry. 2004 Jun;161(6):1079-83 [PMID:
15169696
]
J Manag Care Pharm. 2012 Oct;18(8):650 [PMID:
23127151
]
PLoS Med. 2005 May;2(5):e138 [PMID:
15916457
]
F1000Res. 2020 Jul 15;9:707 [PMID:
33204410
]
PLoS Med. 2011 Apr;8(4):e1000431 [PMID:
21483716
]
Ann Intern Med. 2001 Sep 18;135(6):463-6 [PMID:
11560460
]
Int J Risk Saf Med. 2016 Mar 16;28(1):33-43 [PMID:
27176755
]
Neurology. 1970 May;20(5):1-59 [PMID:
4314823
]
JAMA. 2006 Jun 21;295(23):2787-90 [PMID:
16788134
]
PLoS Med. 2010 Aug;8(8):e1001070 [PMID:
21829331
]
Medicina (Kaunas). 2020 Mar 12;56(3): [PMID:
32178434
]
Drugs Context. 2020 Dec 16;9: [PMID:
33408750
]
Ann Pharmacother. 2013 Jul-Aug;47(7-8):1081-3 [PMID:
23585648
]
PLoS Med. 2007 Jan;4(1):e19 [PMID:
17227134
]
JAMA. 2019 Aug 6;322(5):422-429 [PMID:
31386135
]
J Neurochem. 2014 Feb;128(3):341-3 [PMID:
24410543
]
JAMA. 2000 Sep 13;284(10):1247-55 [PMID:
10979111
]
J Am Board Fam Med. 2020 Mar-Apr;33(2):240-251 [PMID:
32179607
]
N Engl J Med. 2009 Jan 15;360(3):225-35 [PMID:
19144938
]
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100201 [PMID:
33345918
]
Nat Biotechnol. 2009 Nov;27(11):961-2 [PMID:
19898429
]
PLoS Med. 2007 Sep;4(9):e286 [PMID:
17896859
]
Perspect Biol Med. 2007 Winter;50(1):18-31 [PMID:
17259673
]
Chest. 2016 Mar;149(3):886 [PMID:
26836916
]
JAMA Intern Med. 2018 Nov 1;178(11):1451-1457 [PMID:
30264133
]
BMJ. 2019 Oct 23;367:l5766 [PMID:
31645328
]
Ocul Surf. 2022 Oct;26:209-210 [PMID:
35963606
]
Wall St J (East Ed). 2005 Dec 13;:A1, A8 [PMID:
16506304
]
JAMA Intern Med. 2017 Nov 1;177(11):1680-1682 [PMID:
28892525
]
BMJ. 2003 May 31;326(7400):1193-6 [PMID:
12775622
]
J Am Coll Cardiol. 2008 Feb 12;51(6):615-7 [PMID:
18261679
]
Journal Article
4
CITATIONS
4
Total citations
4
Recent citations
4.77
Field Citation Ratio
1.22
Relative Citation Ratio
Word Cloud
Created with Highcharts 10.0.0
Off-Label
marketing
off-label
Use
vs
Marketing:
Part
2:
Marketing-Consequences
Patients
Clinicians
Researchers
drugs
device
ethics
use
Similar Articles
Cited By
(2)
Energy-Based Medical Devices in Plastic Surgery: A Comparison of FDA-Approved Indications to Advertised Claims.
Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.
Posted by
11
X users
26
readers on Mendeley
See more details